Insider Stock Trading History of Labrucherie Gil M


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Labrucherie Gil M since year 2005. The trader's CIK number is 1394875. At the time of this reporting, Labrucherie Gil M is the SVP & Chief Financial Officer of Nektar Therapeutics . (stock ticker symbol NKTR). See this page for all insider trading activities at Nektar Therapeutics .


Stock purchases, sales, and option exercises reported by insider Labrucherie Gil M since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2018-02-16 NKTR Nektar Therapeutics Sale 3,477 82.94 288,382
2017-10-02 NKTR Nektar Therapeutics Option Ex 120,000 11.34 1,360,800
2017-10-02 NKTR Nektar Therapeutics Sale 120,000 24.45 2,934,000
2017-08-16 NKTR Nektar Therapeutics Sale 3,177 19.32 61,379
2017-05-16 NKTR Nektar Therapeutics Sale 3,179 19.55 62,149
2017-03-03 NKTR Nektar Therapeutics Sale 32,494 15.21 494,233
2017-03-02 NKTR Nektar Therapeutics Sale 167,506 15.15 2,537,715
2017-03-03 NKTR Nektar Therapeutics Option Ex 32,494 7.79 253,128
2017-03-02 NKTR Nektar Therapeutics Option Ex 167,506 6.34 1,061,988
2017-02-16 NKTR Nektar Therapeutics Sale 2,359 13.14 30,997
2016-11-16 NKTR Nektar Therapeutics Sale 1,654 13.96 23,089
2016-08-16 NKTR Nektar Therapeutics Sale 3,305 17.56 58,035
2016-05-16 NKTR Nektar Therapeutics Option Ex 2,167 .00 0
2016-05-17 NKTR Nektar Therapeutics Sale 836 13.58 11,352
2016-02-16 NKTR Nektar Therapeutics Option Ex 2,166 .00 0
2016-02-17 NKTR Nektar Therapeutics Sale 827 11.92 9,857
2016-01-19 NKTR Nektar Therapeutics Sale 11,667 14.12 164,738
2016-01-19 NKTR Nektar Therapeutics Option Ex 11,667 6.46 75,368
2015-12-03 NKTR Nektar Therapeutics Option Ex 45,001 6.72 302,406
2015-12-03 NKTR Nektar Therapeutics Sale 45,001 15.87 714,165
2015-11-11 NKTR Nektar Therapeutics Option Ex 45,000 6.72 302,400
2015-11-11 NKTR Nektar Therapeutics Sale 45,000 13.52 608,400
2015-10-06 NKTR Nektar Therapeutics Option Ex 45,000 6.72 302,400
2015-10-06 NKTR Nektar Therapeutics Sale 45,000 10.99 494,550
2015-09-23 NKTR Nektar Therapeutics Option Ex 44,999 6.72 302,393
2015-09-23 NKTR Nektar Therapeutics Sale 44,999 13.04 586,786
2015-08-13 NKTR Nektar Therapeutics Sale 33,333 10.89 362,996
2015-08-13 NKTR Nektar Therapeutics Option Ex 33,333 6.98 232,664
2015-07-14 NKTR Nektar Therapeutics Option Ex 33,334 6.98 232,671
2015-07-14 NKTR Nektar Therapeutics Sale 33,334 11.78 392,674
2014-12-01 NKTR Nektar Therapeutics Sale 30,000 17.00 510,000
2014-11-28 NKTR Nektar Therapeutics Sale 90,000 17.02 1,531,800
2014-12-01 NKTR Nektar Therapeutics Option Ex 30,000 4.65 139,500
2014-11-28 NKTR Nektar Therapeutics Option Ex 90,000 4.65 418,500
2014-11-24 NKTR Nektar Therapeutics Option Ex 10,500 13.02 136,710
2014-11-24 NKTR Nektar Therapeutics Sale 10,500 15.04 157,920
2014-11-03 NKTR Nektar Therapeutics Sale 9,900 13.78 136,422
2014-11-03 NKTR Nektar Therapeutics Option Ex 9,900 11.38 112,662
2011-03-07 NKTR Nektar Therapeutics Option Ex 1,089 .00 0
2009-05-12 NKTR Nektar Therapeutics Option Ex 1,089 .00 0
2009-05-12 NKTR Nektar Therapeutics Sale 395 5.57 2,200
2008-11-14 NKTR Nektar Therapeutics Option Ex 1,122 .00 0
2008-11-14 NKTR Nektar Therapeutics Sale 401 4.37 1,752

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Labrucherie Gil M (SVP & Chief Financial Officer of Nektar Therapeutics at the time of this reporting) see the Securities and Exchange Commission (SEC) website.